Implications of polycystic ovary syndrome for pregnancy and for the health of offspring
- PMID: 26000511
- DOI: 10.1097/AOG.0000000000000852
Implications of polycystic ovary syndrome for pregnancy and for the health of offspring
Abstract
Objective: To study the influence of polycystic ovary syndrome (PCOS) on obstetric and perinatal outcomes and on offspring in childhood.
Methods: Using statewide data linkage systems within Western Australia, 2,566 hospitalized women with a PCOS diagnosis and at least one pregnancy at 20 weeks of gestation or greater, between 1997 and 2011, were compared with 25,660 randomly selected age-matched women not hospitalized with a PCOS diagnosis with regard to perinatal outcomes, congenital anomalies, and general health of offspring. Hospitalizations were categorized by International Classification of Diseases, 10th Revision diagnoses and rates by 10 years by Kaplan-Meier estimates. Polycystic ovary syndrome effects were summarized using adjusted odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CIs) after controlling for maternal and perinatal characteristics, including maternal diabetes and obesity.
Results: Of women with PCOS (n=1,789), 69.7% and 62.9% (n=16,139) of women without PCOS had one or more births. Hospitalizations up to 31 years were examined for 38,361 offspring. Offspring of women with PCOS were at higher risk of preterm birth (15.5% compared with 7.6% OR 1.74, 95% CI 1.53-1.98), perinatal mortality (2.3% compared with 0.7%, OR 1.49, 95% CI 1.02-2.18), more postnatal hospitalizations (14.1% compared with 7.9%, OR 1.21, 95% CI 1.05-1.40), more congenital anomalies (6.3% compared with 4.9%, OR 1.20, 95% CI 1.03-1.40), cardiovascular (1.5% compared with 1.0%, OR 1.37, 95% CI 1.01-1.87), and urogenital defects (2.0% compared with 1.4% OR 1.36, 95% CI 1.03-1.81). Maternal PCOS was associated with increased hospitalizations for their offspring, including metabolic disorder (7.9% compared with 5.3%, HR 1.43, 95% CI 1.26-1.65), disease of the nervous system (9.4% compared with 6.9%, HR 1.17, 95% CI 1.03-1.33), and asthma (6.9% compared with 4.9%, HR 1.32, 95% CI 1.13-1.54).
Conclusion: Controlling for increased perinatal risk, maternal PCOS was associated with a predisposition to adverse health outcomes for their offspring.
Level of evidence: II.
Similar articles
-
Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study.Hum Reprod. 2020 Oct 1;35(10):2336-2347. doi: 10.1093/humrep/deaa192. Hum Reprod. 2020. PMID: 32866965 Free PMC article.
-
Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study.Hum Reprod. 2021 Jul 19;36(8):2345-2357. doi: 10.1093/humrep/deab112. Hum Reprod. 2021. PMID: 34046665 Free PMC article.
-
Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England.BMC Med. 2022 Aug 30;20(1):298. doi: 10.1186/s12916-022-02473-3. BMC Med. 2022. PMID: 36038914 Free PMC article.
-
The role of maternal obesity in infant outcomes in polycystic ovary syndrome-A systematic review, meta-analysis, and meta-regression.Obes Rev. 2019 Jun;20(6):842-858. doi: 10.1111/obr.12832. Epub 2019 Feb 20. Obes Rev. 2019. PMID: 30785659
-
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.Hum Reprod Update. 2006 Nov-Dec;12(6):673-83. doi: 10.1093/humupd/dml036. Epub 2006 Aug 4. Hum Reprod Update. 2006. PMID: 16891296 Review.
Cited by
-
A Rat Model of Maternal Polycystic Ovary Syndrome Shows that Exposure to Androgens In Utero Results in Dysbiosis of the Intestinal Microbiota and Metabolic Disorders of the Newborn Rat.Med Sci Monit. 2019 Dec 9;25:9377-9391. doi: 10.12659/MSM.918600. Med Sci Monit. 2019. PMID: 31815927 Free PMC article.
-
Cardiovascular disease risk in offspring of polycystic ovary syndrome.Front Endocrinol (Lausanne). 2022 Nov 30;13:977819. doi: 10.3389/fendo.2022.977819. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531474 Free PMC article. Review.
-
The Mechanism of Androgen Actions in PCOS Etiology.Med Sci (Basel). 2019 Aug 28;7(9):89. doi: 10.3390/medsci7090089. Med Sci (Basel). 2019. PMID: 31466345 Free PMC article. Review.
-
Gestational Hyperandrogenism in Developmental Programming.Endocrinology. 2017 Feb 1;158(2):199-212. doi: 10.1210/en.2016-1801. Endocrinology. 2017. PMID: 27967205 Free PMC article. Review.
-
Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives.Front Endocrinol (Lausanne). 2022 Jul 5;13:936948. doi: 10.3389/fendo.2022.936948. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35865312 Free PMC article. Review.
References
-
- Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:671–83.
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7.
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
-
- Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online 2004;8:644–8.
-
- Agrawal R, Sharma S, Bekir J, Conway G, Bailey J, Balen AH, et al.. Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women. Fertil Steril 2004;82:1352–7.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials